JWH-133

JWH-133
(IUPAC) ime
	(6aR,10aR)-3-(1,1-Dimetilbutil)-6a,7,10,10a-tetrahidro -6,6,9-trimetil-6H-dibenzo[b,d]piran
Klinički podaci
Identifikatori
CAS broj	259869-55-1
ATC kod	nije dodeljen
PubChem	6918505
ChemSpider	5293702
ChEMBL	CHEMBL371214
Hemijski podaci
Formula	C22H32O
Mol. masa	312,489 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C22H32O/c1-7-12-21(3,4)16-9-10-17-18-13-15(2)8-11-19(18)22(5,6)23-20(17)14-16/h8-10,14,18-19H,7,11-13H2,1-6H3/t18-,19+/m0/s1 ; Key: YSBFLLZNALVODA-RBUKOAKNSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

JWH-133 je potentan i selektivan agonist CB₂ receptora, sa Ki od 3,4 nM i selektivnošću od oko 200 puta za CB₂ u odnosu na CB₁ receptore.

JWH-133, kao i WIN 55,212-2 i HU-210, sprečavaju inflamaciju uzrokovanu beta amiloidnim proteinima koji učestvuju u Alzheimerovoj bolesti. On isto tako sprečava kognitivno pogoršanje i gubitak neuronskih markera. Ovo antiinflamatorno dejstvo je indukovano putem dejstva agonista na kanabinoidni receptor, čime se sprečava aktivacija mikroglija koja uzrokuje zapaljenje. Kanabinoidi potpuno sprečavaju neurotoksičnost vezanu za aktivaciju mikroglija u modelima na pacovima.

JWH-133 je potencijalno koristan kao lek protiv kancera.^[5]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Cristina Blazquz, M. Llanos Casanova, Anna Planas, Teresa Gómez Del Pulgar, Concepción Villanueva, María J. Fernández-Aceñero, Julián Aragonés, John W. Huffman, José L. Jorcano and Manuel Guzmán (January 2003). nhibition of tumor angiogenesis by cannabinoids. DOI:10.1096/fj.02-0795fje.

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[5] Cristina Blazquz, M. Llanos Casanova, Anna Planas, Teresa Gómez Del Pulgar, Concepción Villanueva, María J. Fernández-Aceñero, Julián Aragonés, John W. Huffman, José L. Jorcano and Manuel Guzmán (January 2003). nhibition of tumor angiogenesis by cannabinoids. DOI:10.1096/fj.02-0795fje.

[1]

[2]

[3]

[4]

[5]

JWH-133

From Wikipedia, the free encyclopedia · View on Wikipedia